Home » Newsletters » BioWorld Asia

BioWorld Asia

July 12, 2000

View Archived Issues

Arrow Completes #11M Round For Antimicrobial Programs

EU Patent Plan Would Reduce Costs, Encourage Innovation

Drug-Resistant HIV Strains Arise Prior To Start Of Drug Treatment

Ontario Invests In Three Centers, Plans To Become Biotech Hub

Brandys Steps Down At Genset; Director Assumes Top Positions

British Biotech Changes Focus, Seeks To Move Past Marimastat

Roche, Atugen Collaborate To Study Gene Function In Vivo

UK Genetics Commission Plans Open Discussion On Principles

Israeli Biotech Companies Continue Moving Forward

Australian Investors Launch Biotechnology Venture Fund

Lion Bioscience Seeks $191M In IPO On Nasdaq, Neuer Markt

Prodi Recognizes EU Need To Restore Confidence In Biotech

EPO Upholds CAT Patent On Phage Display Of Antibodies

NicOx Gets Positive Results In Early Dermatology Trial

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...